Published on

Medicine – Neoplastic Complications of HIV Infection

Neoplastic complications are an important cause of morbidity and mortality in patients with human immunodeficiency virus (HIV) infection.

HIV increases the risk of certain malignancies through immunosuppression, impaired immune surveillance, chronic inflammation and persistent infection with oncogenic viruses.

Four Important Neoplastic Complications
  1. Kaposi sarcoma – associated with HHV-8.
  2. Non-Hodgkin lymphoma.
  3. Cervical carcinoma – associated with high-risk HPV.
  4. Oral squamous cell carcinoma.

1. Kaposi Sarcoma

Kaposi sarcoma is an angioproliferative malignancy associated with human herpesvirus 8 (HHV-8), also known as Kaposi sarcoma-associated herpesvirus (KSHV).

It is one of the classical AIDS-defining malignancies.

Clinical Appearance

Illustration: Multiple violaceous patches, plaques and nodules on the skin.

View real clinical photographs on Wikimedia Commons

Pathogenesis

  • HHV-8 infects cells of endothelial lineage.
  • Viral infection promotes abnormal vascular and spindle-cell proliferation.
  • HIV-associated immune dysfunction facilitates tumour development.

Pathogenesis Flowchart

HHV-8 Infection HIV-Associated Immune Dysfunction Abnormal Vascular and Spindle-Cell Proliferation Kaposi Sarcoma

Clinical Features

  • Red, purple, brown or violaceous patches, plaques and nodules.
  • Lesions may occur on the skin, oral mucosa and internal organs.
  • Common sites include lower limbs, face and hard palate.
  • Cutaneous lesions are often painless.
  • Advanced disease may involve the gastrointestinal tract, lymph nodes or lungs.

Visceral Involvement

Site Manifestations
SkinViolaceous patches, plaques or nodules
Oral cavityPurple-red lesions, especially on the palate
Gastrointestinal tractBleeding, abdominal pain or obstruction
LungsDyspnoea, cough, hypoxaemia or haemoptysis
Lymph nodesLymphadenopathy

Histological Features

  • Spindle-cell proliferation.
  • Slit-like vascular spaces.
  • Extravasated red blood cells.
  • Hemosiderin deposits.
  • HHV-8 LANA positivity on immunohistochemistry.

Treatment

  • Antiretroviral therapy (ART).
  • Local treatment for selected limited lesions.
  • Systemic chemotherapy for extensive or visceral disease.
  • Common agents include liposomal doxorubicin and paclitaxel.
Examination Point: Kaposi sarcoma is an HHV-8-associated, AIDS-defining malignancy characterised by violaceous vascular lesions.

2. Non-Hodgkin Lymphoma (NHL)

Non-Hodgkin lymphoma comprises a heterogeneous group of lymphoid malignancies.

Patients with HIV have an increased risk of aggressive B-cell lymphomas, particularly with advanced immunosuppression.

Histopathology

Schematic: Dense proliferation of atypical lymphoid cells. Actual histology varies by lymphoma subtype.

View real lymphoma histopathology images

Pathogenesis

  • HIV-associated immune dysfunction.
  • Chronic B-cell stimulation.
  • Impaired control of oncogenic viruses.
  • Epstein–Barr virus (EBV) is associated with many HIV-related lymphomas.

Important Types

Lymphoma Characteristics
Diffuse large B-cell lymphomaCommon aggressive B-cell lymphoma
Burkitt lymphomaHighly proliferative; associated with MYC rearrangement
Primary CNS lymphomaFrequently EBV-associated in advanced HIV
Plasmablastic lymphomaOften extranodal, including the oral cavity
Primary effusion lymphomaHHV-8-associated; often presents with body-cavity effusion

Clinical Features

  • Painless lymphadenopathy.
  • Fever.
  • Night sweats.
  • Unintentional weight loss.
  • Fatigue.
  • Extranodal involvement of the gastrointestinal tract, bone marrow or CNS.

Fever, night sweats and significant unintentional weight loss are commonly referred to as B symptoms.

Primary CNS Lymphoma

  • Headache.
  • Seizures.
  • Focal neurological deficits.
  • Altered mental status.

In advanced HIV, primary CNS lymphoma is an important differential diagnosis for cerebral toxoplasmosis.

Diagnosis

  • Tissue biopsy and histopathology.
  • Immunophenotyping.
  • Imaging for staging.
  • Bone marrow or cerebrospinal fluid investigations when indicated.

Treatment

  • Subtype-specific combination chemotherapy.
  • Rituximab for appropriate CD20-positive lymphomas.
  • ART with attention to drug interactions.
  • CNS-directed treatment when indicated.
Examination Point: Certain aggressive B-cell lymphomas, including Burkitt lymphoma, immunoblastic lymphoma and primary CNS lymphoma, are AIDS-defining malignancies.

3. Cervical Carcinoma

Cervical carcinoma is strongly associated with persistent infection by high-risk human papillomavirus (HPV).

Invasive cervical carcinoma is an AIDS-defining malignancy.

Pathogenesis

HIV-related immunosuppression reduces the ability to control HPV infection, increasing the likelihood of persistent infection, cervical intraepithelial neoplasia (CIN) and invasive carcinoma.

Progression Diagram

High-Risk HPV Infection Especially HPV 16 and 18 Persistent HPV Infection Impaired immune control Cervical Intraepithelial Neoplasia (CIN) Invasive Cervical Carcinoma

Simplified pathway: progression is not inevitable. Screening and treatment of precancerous lesions can prevent invasive cancer.

Important HPV Types

HPV Type Clinical Significance
16High-risk oncogenic type
18High-risk oncogenic type
31, 33, 45 and othersAdditional high-risk types
6 and 11Low-risk types causing most anogenital warts

Clinical Features

  • Early cervical cancer may be asymptomatic.
  • Postcoital bleeding.
  • Intermenstrual bleeding.
  • Abnormal vaginal discharge.
  • Pelvic pain.
  • Urinary or bowel symptoms in advanced disease.

Prevention and Screening

  • HPV vaccination.
  • Regular cervical screening according to HIV-specific recommendations.
  • HPV testing and/or cervical cytology, depending on local protocols.
  • Colposcopy and biopsy when indicated.
  • Treatment of precancerous cervical lesions.

Treatment

Treatment depends on disease stage and may include surgery, radiotherapy, chemotherapy or combined chemoradiotherapy. ART should be continued or optimised alongside cancer treatment.

Examination Point: Invasive cervical carcinoma is an AIDS-defining malignancy associated with persistent high-risk HPV infection.

4. Oral Squamous Cell Carcinoma

Oral squamous cell carcinoma (OSCC) is a malignant tumour arising from squamous epithelial cells lining the oral cavity.

It can occur in people living with HIV, but it is not an AIDS-defining malignancy.

Clinical Appearance

Ulcer

Illustration: Irregular oral ulcer with an indurated border.

View real oral carcinoma photographs

Risk Factors

  • Tobacco smoking or chewing.
  • Alcohol consumption.
  • Betel quid or areca nut use.
  • Previous oral epithelial dysplasia.
  • Immunosuppression and other host factors.

HPV has a strong causal association with oropharyngeal squamous cell carcinoma, particularly cancers of the tonsils and base of tongue. Its role in true oral cavity squamous cell carcinoma is less established.

Clinical Features

  • Persistent oral ulcer.
  • Non-healing mucosal lesion.
  • Indurated or irregular mass.
  • Red or white mucosal patches.
  • Pain or difficulty swallowing.
  • Cervical lymphadenopathy in advanced disease.

Common sites include the lateral tongue and floor of the mouth.

Histological Features

  • Invasive malignant squamous epithelial cells.
  • Nuclear pleomorphism.
  • Atypical mitotic figures.
  • Keratin pearl formation in well-differentiated tumours.
  • Invasion into underlying connective tissue.

Diagnosis

A persistent suspicious oral lesion requires clinical examination and tissue biopsy.

Treatment

  • Surgical excision.
  • Neck dissection when indicated.
  • Radiotherapy.
  • Systemic therapy for selected advanced disease.
Examination Point: Oral squamous cell carcinoma is not an AIDS-defining malignancy. Distinguish oral cavity carcinoma from HPV-related oropharyngeal carcinoma.

5. Comparison of Neoplastic Complications

Malignancy Association AIDS-Defining?
Kaposi sarcomaHHV-8Yes
Certain non-Hodgkin lymphomasOften EBV; HHV-8 in specific subtypesYes
Invasive cervical carcinomaHigh-risk HPVYes
Oral squamous cell carcinomaTobacco, alcohol, areca nut and other factorsNo

6. Pathogenesis of HIV-Associated Malignancies

HIV Infection CD4+ T-Cell Depletion Immune dysfunction Impaired Immune Surveillance and Viral Control Increased Cancer Risk HHV-8 Kaposi sarcoma EBV / Other Factors Certain lymphomas High-Risk HPV Cervical carcinoma Multiple Risk Factors Oral squamous carcinoma

Simplified conceptual diagram. Cancer mechanisms vary by tumour type, and immunosuppression is not the sole cause of every malignancy.

7. High-Yield Examination Summary

Kaposi Sarcoma

  • Associated with HHV-8.
  • Violaceous patches, plaques and nodules.
  • May involve skin, oral cavity, lungs and gastrointestinal tract.
  • AIDS-defining malignancy.

Non-Hodgkin Lymphoma

  • Aggressive B-cell lymphomas are particularly important.
  • EBV is associated with many cases, depending on subtype.
  • May present with lymphadenopathy, B symptoms or extranodal disease.
  • Certain subtypes are AIDS-defining.

Cervical Carcinoma

  • Associated with high-risk HPV, especially types 16 and 18.
  • Persistent infection may progress through CIN to invasive carcinoma.
  • Invasive cervical carcinoma is AIDS-defining.

Oral Squamous Cell Carcinoma

  • May present as a persistent, indurated oral ulcer or mass.
  • Tobacco, alcohol and areca nut are important risk factors.
  • Not an AIDS-defining malignancy.
Most Important Examination Point

The classical AIDS-defining malignancies are:

  1. Kaposi sarcoma.
  2. Certain non-Hodgkin lymphomas.
  3. Invasive cervical carcinoma.

Oral squamous cell carcinoma may occur in patients with HIV but is not an AIDS-defining malignancy.

Kembara Xtra – Medicine Revision Notes

Image description
0 Comments